Southport Capital Management’s Gilead Sciences GILD Stock Holding History

Southport Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,814	Closed	-$277K	–	260
2021 Q4	$277K	Buy	+3,814	New	+$263K	0.05%	262
2021 Q3	–	Sell	-3,355	Closed	-$231K	–	260
2021 Q2	$231K	Buy	+3,355	New	+$224K	0.06%	275
2018 Q4	–	Sell	-650	Closed	-$50K	–	279
2018 Q3	$50K	Buy	+650	New	+$49.1K	0.02%	257
2016 Q3	–	Sell	-867	Closed	-$72K	–	264
2016 Q2	$72K	Buy	+867	New	+$76.9K	0.04%	260
2015 Q2	–	Sell	-5,900	Closed	-$579K	–	167
2015 Q1	$579K	Buy	5,900 +290	+5%	+$29.4K	0.34%	81
2014 Q4	$529K	Buy	+5,610	New	+$580K	0.32%	83

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Southport Capital Management's GILD Position: Q1 2022 in Review

Southport Capital Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 3,814 shares — an estimated $277K sold.

Southport Capital Management first reported a position in GILD in Q4 2014 and held it in 6 quarters. The position peaked at $579K in Q1 2015. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Southport Capital Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Southport Capital Management sold 3,814 Gilead Sciences shares in Q1 2022, an estimated $277K.
Southport Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 6 quarters.
Southport Capital Management's Gilead Sciences position peaked at $579K in Q1 2015.
1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.